A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate
James W. Hodge(National Cancer Institute), Judy Kantor(National Cancer Institute), Clyde W. Wheeler(University of Illinois Chicago), Dennis Panicali(Fox Chase Cancer Center), Linda Gritz, Jeffrey Schlom(National Institutes of Health), Joseph E. Tomaszewski(American Society for Bone and Mineral Research), Barry Levine(University of Illinois Chicago), Susan J. Donohue(National Cancer Institute)
Cited by 106
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|975